These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21928123)

  • 1. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
    Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J
    World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
    Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the KIT/stem cell factor axis in renal tumours.
    Horstmann M; Hennenlotter J; Geiger LM; Vogel U; Schmid H; Kuehs U; Stenzl A; Bedke J
    Anticancer Res; 2012 Oct; 32(10):4339-45. PubMed ID: 23060556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
    Iakymenko OA; Delma KS; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
    [No Abstract]   [Full Text] [Related]  

  • 8. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms.
    Shen SS; Krishna B; Chirala R; Amato RJ; Truong LD
    Mod Pathol; 2005 Jul; 18(7):933-40. PubMed ID: 15696118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.
    Yasir S; Herrera L; Gomez-Fernandez C; Reis IM; Umar S; Leveillee R; Kava B; Jorda M
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):454-61. PubMed ID: 22417859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
    Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
    BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
    Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
    Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms].
    Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma.
    Amend B; Hennenlotter J; Scharpf M; Kruck S; Kuehs U; Senger E; Merseburger AS; Kuczyk MA; Sievert KD; Stenzl A; Bedke J
    World J Urol; 2012 Jun; 30(3):353-9. PubMed ID: 21822918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of cadherin17 in metanephric adenoma and its value in differential diagnosis].
    Wang X; Wu N; Yang WR; Shi SS; Ma HH; Wei X; Zhou XJ; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2016 Jul; 45(7):457-61. PubMed ID: 27430690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
    Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.